4.5 Article

The role of progranulin in diabetes and kidney disease

Journal

DIABETOLOGY & METABOLIC SYNDROME
Volume 7, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/s13098-015-0112-6

Keywords

Progranulin; Adipokine; Obesity; Diabetes; Kidney disease; Inflammation

Funding

  1. Centro de Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
  2. Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre (FIPE/HCPA)

Ask authors/readers for more resources

Progranulin (PGRN) is a cysteine rich secreted protein, expressed in epithelial cells, immune cells, neurons, and adipocytes. It was first identified for its growth factor-like properties, being involved in early embryogenesis and tissue remodeling, acting as an anti-inflammatory molecule. In the central nervous system, PGRN has neurotrophic and neuroprotective actions. There is also evidence of PGRN effects on cancer, contributing to tumor proliferation, invasion and cell survival. Recently, PGRN was recognized as an adipokine related to obesity and insulin resistance, revealing its metabolic function and pro-inflammatory properties. In obesity and type 2 diabetes mellitus, PGRN levels are increased. In renal disease, there is a relevant association, however, it is not known if it could contribute to kidney damage or if it is only a route of PGRN elimination. PGRN is an emerging molecule which demands studies in different fields. Possibly, it plays distinct functions in different tissues/cells and metabolic conditions. Here, we discuss potential mechanisms and recent data of PGRN pro-inflammatory actions, regarding obesity, insulin resistance, type 2 diabetes mellitus and kidney disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Endocrinology & Metabolism

No effect of acidification or freezing on urinary metanephrine levels

L. C. Pinto, C. K. Kramer, J. L. Camargo, L. H. Canani, J. L. Gross, C. B. Leitao

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2020)

Article Surgery

Plasma progranulin levels in obese patients before and after Roux-en-Y gastric bariatric surgery: a longitudinal study

Michele de Souza Kraemer, Milene Moehlecke, Jakeline Rheinheimer, Luis Henrique Canani, Cristiane Bauermann Leitao, Bruna Bellincanta Nicoletto

SURGERY FOR OBESITY AND RELATED DISEASES (2020)

Article Multidisciplinary Sciences

Could serum zonulin be an intestinal permeability marker in diabetes kidney disease?

Larissa Salomoni Carpes, Bruna Bellincanta Nicoletto, Luis Henrique Canani, Jakeline Rheinhemer, Daisy Crispim, Gabriela Correa Souza

Summary: Zonulin, a protein linked to various health conditions, was found to be increased in T2DM patients without renal disease, indicating impaired intestinal permeability. Its association with renal outcomes suggests its potential use as a disease monitoring marker, but further research is needed on the underlying mechanisms.

PLOS ONE (2021)

Review Endocrinology & Metabolism

Advances in GLP-1 treatment: focus on oral semaglutide

Freddy G. Eliaschewitz, Luis Henrique Canani

Summary: Oral semaglutide effectively reduces blood glucose and body weight in patients with T2D, demonstrating cardiovascular safety. Adverse events associated with oral semaglutide, like other GLP-1 RA drugs, are mainly related to the gastrointestinal tract.

DIABETOLOGY & METABOLIC SYNDROME (2021)

Article Endocrinology & Metabolism

The rs2442598 polymorphism in the ANGPT-2 gene is associated with risk for diabetic retinopathy in patients with type 1 diabetes mellitus in a Brazilian population

Cristine Dieter, Natalia Emerim Lemos, Nathalia Rodrigues de Faria Correa, Aline Rodrigues Costa, Luis Henrique Canani, Daisy Crispim, Andrea Carla Bauer

Summary: This study revealed an association between the ANGPT-2 rs2442598 A allele and risk for DR in T1DM patients, with the A/A genotype showing a significant association with DR risk.

ARCHIVES OF ENDOCRINOLOGY METABOLISM (2021)

Article Endocrinology & Metabolism

The A allele of the rs759853 single nucleotide polymorphism in the AKR1B1 gene confers risk for diabetic kidney disease in patients with type 2 diabetes from a Brazilian population

Cristine Dieter, Natalia Emerim Lemos, Nathalia Rodrigues de Faria Correa, Felipe Mateus Pellenz, Luis Henrique Canani, Daisy Crispim, Andrea Carla Bauer

Summary: This study investigated the association between the rs759853 polymorphism in the AKR1B1 gene and diabetic kidney disease (DKD) in Brazilian patients with type 2 diabetes mellitus (T2DM). The results suggest that the A/A genotype of the rs759853 polymorphism is associated with an increased risk for DKD in this population.

ARCHIVES OF ENDOCRINOLOGY METABOLISM (2022)

Article Endocrinology & Metabolism

The rs2304256 Polymorphism in TYK2 Gene Is Associated with Protection for Type 1 Diabetes Mellitus

Felipe Mateus Pellenz, Cristine Dieter, Guilherme Coutinho Kullmann Duarte, Luis Henrique Canani, Bianca Marmontel de Souza, Daisy Crispim

Summary: The TYK2 rs2304256 SNP is associated with protection against T1DM in a Southern Brazilian population, with the A allele showing a protective effect against the disease.

DIABETES & METABOLISM JOURNAL (2021)

Review Ophthalmology

Association of polymorphisms in the erythropoietin gene with diabetic retinopathy: a case-control study and systematic review with meta-analysis

Luis Fernando Castagnino Sesti, Renan Cesar Sbruzzi, Evelise Regina Polina, Douglas dos Santos Soares, Daisy Crispim, Luis Henrique Canani, Katia Goncalves dos Santos

Summary: The rs1617640 polymorphism in the EPO gene is suggestively associated with diabetic retinopathy (DR), particularly non-proliferative DR and DR in patients with type 1 diabetes (T1DM). However, no association is found between the rs507392 and rs551238 polymorphisms and DR.

BMC OPHTHALMOLOGY (2022)

Article Endocrinology & Metabolism

The 2021-2022 position of Brazilian Diabetes Society on diabetic kidney disease (DKD) management: an evidence-based guideline to clinical practice. Screening and treatment of hyperglycemia, arterial hypertension, and dyslipidemia in the patient with DKD

Joao Roberto de Sa, Erika Bevilaqua Rangel, Luis Henrique Canani, Andrea Carla Bauer, Gustavo Monteiro Escott, Themis Zelmanovitz, Marcello Casaccia Bertoluci, Sandra Pinho Silveiro

Summary: The review on Diabetic Kidney Disease by SBD provides evidence-based guidelines for management with recommendations categorized by levels of evidence and degrees of agreement from panelists. Intensive glycemic control, blood pressure management, and the use of specific medications are essential for preventing advanced stages of DKD.

DIABETOLOGY & METABOLIC SYNDROME (2022)

Article Peripheral Vascular Disease

The rs705708 A allele of the ERBB3 gene is associated with lower prevalence of diabetic retinopathy and arterial hypertension and with improved renal function in type 1 diabetic patients

Eloisa Toscan Massignam, Cristine Dieter, Tais Silveira Assmann, Guilherme Coutinho Kullmann Duarte, Andrea Carla Bauer, Luis Henrique Canani, Daisy Crispim

Summary: The ERBB3 and PA2G4 gene mutations were not found to be associated with T1DM. However, the ERBB3 rs705708 A allele was associated with a lower prevalence of diabetic retinopathy and arterial hypertension, as well as improved renal function.

MICROVASCULAR RESEARCH (2022)

Article Biochemistry & Molecular Biology

Elevated Extracellular HSP72 and Blunted Heat Shock Response in Severe COVID-19 Patients

Mariana Kras Borges Russo, Lucas Stahlhofer Kowalewski, Gabriella Richter da Natividade, Carlos Henrique de Lemos Muller, Helena Trevisan Schroeder, Patricia Martins Bock, Layane Ramos Ayres, Bernardo Urbano Cardoso, Caroline Zanotto, Julia Tsao Schein, Tatiana Helena Rech, Daisy Crispim, Luis Henrique Canani, Rogerio Friedman, Cristiane Bauermann Leitao, Fernando Gerchman, Mauricio Krause

Summary: In this study, it was found that patients with severe COVID-19 have elevated levels of plasma eHSP72 and a blunted HSR, regardless of the presence of diabetes. These results may explain the uncontrolled inflammation and the increased risk of developing type 2 diabetes after SARS-CoV-2 infection.

BIOMOLECULES (2022)

Article Biochemistry & Molecular Biology

The rs3931283/PVT1 and rs7158663/MEG3 polymorphisms are associated with diabetic kidney disease and markers of renal function in patients with type 2 diabetes mellitus

Cristine Dieter, Natalia Emerim Lemos, Eliandra Girardi, Denise Taurino Ramos, Felipe Mateus Pellenz, Luis Henrique Canani, Tais Silveira Assmann, Daisy Crispim

Summary: This study investigated the association of six lncRNA gene polymorphisms with diabetic kidney disease (DKD) in patients with type 2 diabetes mellitus (T2DM). The study found that the rs3931283/PVT1 G/G genotype was associated with the risk of DKD and markers of renal function, while the rs7158663/MEG3 G/G genotype was associated with protection against severe DKD and better renal function.

MOLECULAR BIOLOGY REPORTS (2023)

Article Genetics & Heredity

Polymorphisms in ACE1, TMPRSS2, IFIH1, IFNAR2, and TYK2 Genes Are Associated with Worse Clinical Outcomes in COVID-19

Cristine Dieter, Leticia de Almeida Brondani, Natalia Emerim Lemos, Ariell Freires Schaeffer, Caroline Zanotto, Denise Taurino Ramos, Eliandra Girardi, Felipe Mateus Pellenz, Joiza Lins Camargo, Karla Suzana Moresco, Lucas Lima da Silva, Mariana Rauback Aubin, Mayara Souza de Oliveira, Tatiana Helena Rech, Luis Henrique Canani, Fernando Gerchman, Cristiane Bauermann Leitao, Daisy Crispim

Summary: Although age, sex, and comorbidities play a role in the severity of COVID-19, genetic polymorphisms in ACE1, ACE2, DPP9, IFIH1, IFNAR2, IFNL4, TLR3, TMPRSS2, and TYK2 also contribute to the variation in disease severity. This study found that specific genotypes and alleles in these genes are associated with increased risk of ICU admission and death in COVID-19 patients, especially among females and non-white individuals. Moreover, interactions between these polymorphisms further increase the risk of worse outcomes.

GENES (2023)

Article Endocrinology & Metabolism

Polymorphisms in TIE2 and ANGPT-1 genes are associated with protection against diabetic retinopathy in a Brazilian population

Cristine Dieter, Natalia Emerim Lemos, Nathalia Rodrigues de Faria Correa, Tais Silveira Assmann, Felipe Mateus Pellenz, Luis Henrique Canani, Leticia de Almeida Brondani, Andrea Carla Bauer, Daisy Crispim

Summary: This study investigated the association between SNPs in the TIE2 and ANGPT-1 genes and diabetic retinopathy (DR). The study included 603 patients with type 2 diabetes mellitus (T2DM) and DR as cases, and 388 patients with T2DM for more than 10 years without DR as controls. The results showed that certain genotypes and alleles of TIE2 and ANGPT-1 SNPs were associated with protection against DR in a Brazilian population.

ARCHIVES OF ENDOCRINOLOGY METABOLISM (2023)

Article Biochemistry & Molecular Biology

The lncRNA MALAT1 is upregulated in urine of type 1 diabetes mellitus patients with diabetic kidney disease

Cristine Dieter, Natalia Emerim Lemos, Eliandra Girardi, Denise Taurino Ramos, Nathalia Rodrigues de Faria Correa, Luis Henrique Canani, Andrea Carla Bauer, Tais Silveira Assmann, Daisy Crispim

Summary: Long non-coding RNAs (lncRNAs) have a significant role in gene expression regulation and have been associated with various human diseases, including diabetes kidney disease (DKD). This study aimed to compare the expressions of lncRNAs MALAT1 and TUG1 in urine samples of type 1 diabetes mellitus (T1DM) patients with and without DKD. The results showed upregulation of MALAT1 in T1DM patients with DKD, suggesting its potential involvement in DKD development.

GENETICS AND MOLECULAR BIOLOGY (2023)

No Data Available